ロード中...
Therapy of lower respiratory tract infections with moxalactam.
Moxalactam was evaluated in the therapy of lower respiratory tract infections in 40 patients. The most common organisms isolated were Streptococcus pneumoniae (37.2%) and Haemophilus influenzae (21.5%). Gram-negative enteric organisms were isolated from six patients. No patient was evaluated as a tr...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1981
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC181526/ https://ncbi.nlm.nih.gov/pubmed/6457557 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|